SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.   20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) March 17, 2008

ICU MEDICAL, INC.
(Exact name of registrant as specified in its charter)
 
DELAWARE	0-19974	33-0022692	
(State or other jurisdiction of incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)	
 
951 Calle Amanecer, San Clemente, California	92673	
(Address of principal executive offices)	(Zip Code)	
 
(949) 366-2183
Registrant’s telephone number, including area code

N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

INFORMATION TO BE INCLUDED IN THE REPORT

Item 1.01      Entry Into a Material Definitive Agreement
 
On March 17, 2008 the employment agreement of an officer was amended as follows:

Mr. Lamb, who will become Chief Financial Officer effective April 1, 2008: base compensation increased to $210,000 annually, effective April 1, 2008.

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

Date:  March 19, 2008

ICU MEDICAL, INC.

/s/ Francis J. O’Brien
Francis J. O'Brien
Secretary, Treasurer and
Chief Financial Officer